Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -20.02% is 156% below its 5-year average of -7.81%, near the high end of its 5-year range (-303.38%–31.96%).
19.69% above its 12-month average of -24.93%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): 1.52%.
NET PROFIT MARGIN
-20.02%
NET PROFIT MARGIN AVG TTM
-24.93%
NET PROFIT MARGIN AVG 3Y
-6.26%
NET PROFIT MARGIN AVG 5Y
-7.81%
NET PROFIT MARGIN AVG 10Y
5.33%
NET PROFIT MARGIN AVG 15Y
3.66%
NET PROFIT MARGIN AVG 20Y
5.03%
CURRENT VS TTM AVG
+19.69%
CURRENT VS 3Y AVG
-219.91%
CURRENT VS 5Y AVG
-156.46%
CURRENT VS 10Y AVG
-475.92%
CURRENT VS 15Y AVG
-646.86%
CURRENT VS 20Y AVG
-498.03%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 517 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Azenta, Inc.
Market Cap
$2.05B
Net Profit Margin
-20.02%
TTM Avg
-24.93%
3Y Avg
-6.26%
5Y Avg
-7.81%
Market Cap
$2.05B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
Market Cap
$1.99B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$2.04B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$2.07B
Net Profit Margin
15.03%
TTM Avg
11.31%
3Y Avg
2.06%
5Y Avg
-9.89%
Market Cap
$2.02B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
Market Cap
$2.02B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
Market Cap
$1.99B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
Market Cap
$1.99B
Net Profit Margin
-15.82%
TTM Avg
-37.57%
3Y Avg
-42.30%
5Y Avg
-41.11%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Azenta, Inc. (AZTA) | $2.05B | -20.02% | -24.93% | -6.26% | -7.81% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | -40.90% | 5.22% | -37.29% | -215.44% |
| Immunome, Inc. (IMNM)vs › | $1.99B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Alvotech (ALVO)vs › | $2.04B | -36.51% | -21.30% | -316.14% | -299.31% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.07B | 15.03% | 11.31% | 2.06% | -9.89% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 100.84% | 51.96% | -5.31% | -103.82% |
| AxoGen, Inc. (AXGN)vs › | $2.02B | -13.36% | -6.14% | -11.71% | -14.87% |
| Absci Corporation (ABSI)vs › | $1.99B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.99B | -15.82% | -37.57% | -42.30% | -41.11% |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 7.13% | 6.55% | 5.96% | 5.57% |
Operating Margin
-3.5%
Net Profit Margin
-20.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 1.52% |
| 2026-03-31 | -111.05% |
| 2025-12-31 | -10.38% |
| 2025-09-30 | 31.96% |
| 2025-06-30 | -36.69% |
| 2025-03-31 | -28.21% |
| 2024-12-31 | -7.46% |
| 2024-09-30 | -4.41% |
| 2024-06-30 | -4.56% |
| 2024-03-31 | -100.39% |
| 2023-12-31 | -11.09% |
| 2023-09-30 | 1.96% |
| 2023-06-30 | -1.48% |
| 2023-03-31 | -3.32% |
| 2022-12-31 | -6.30% |
| 2022-09-30 | -16.14% |
| 2022-06-30 | -6.46% |
| 2022-03-31 | -303.38% |
| 2021-12-31 | 31.02% |
| 2021-09-30 | 15.92% |
| 2021-06-30 | 30.34% |
| 2021-03-31 | 18.33% |
| 2020-12-31 | 22.03% |
| 2020-09-30 | 26.77% |
| 2020-06-30 | 6.22% |
| 2020-03-31 | 4.14% |
| 2019-12-31 | 6.20% |
| 2019-09-30 | 2.03% |
| 2019-06-30 | 3.56% |
| 2019-03-31 | 1.72% |
| 2018-12-31 | 8.04% |
| 2018-09-30 | 6.48% |
| 2018-06-30 | 13.18% |
| 2018-03-31 | 42.70% |
| 2017-12-31 | 11.56% |
| 2017-09-30 | 9.56% |
| 2017-06-30 | 9.55% |
| 2017-03-31 | 8.27% |
| 2016-12-31 | 8.67% |
| 2016-09-30 | 6.69% |
| 2016-06-30 | 5.80% |
| 2016-03-31 | -62.05% |
| 2015-12-31 | -3.87% |
| 2015-09-30 | 4.50% |
| 2015-06-30 | 5.30% |
| 2015-03-31 | 1.95% |
| 2014-12-31 | -2.23% |
| 2014-09-30 | 0.20% |
| 2014-06-30 | 20.86% |
| 2014-03-31 | 2.53% |
| 2013-12-31 | 2.77% |
| 2013-09-30 | 5.09% |
| 2013-06-30 | 1.31% |
| 2013-03-31 | -0.46% |
| 2012-12-31 | -9.42% |
| 2012-09-30 | 97.29% |
| 2012-06-30 | 5.72% |
| 2012-03-31 | 6.81% |
| 2011-12-31 | 2.49% |
| 2011-09-30 | 9.24% |
| 2011-06-30 | 35.56% |
| 2011-03-31 | 13.80% |
| 2010-12-31 | 13.17% |
| 2010-09-30 | 13.31% |
| 2010-06-30 | 10.57% |
| 2010-03-31 | 14.17% |
| 2009-12-31 | -2.63% |
| 2009-09-30 | -22.61% |
| 2009-06-30 | -58.67% |
| 2009-03-31 | -408.97% |
| 2008-12-31 | -47.77% |
| 2008-09-30 | -202.03% |
| 2008-06-30 | -8.33% |
| 2008-03-31 | -5.87% |
| 2007-12-31 | -0.96% |
| 2007-09-30 | -0.78% |
| 2007-06-30 | 11.99% |
| 2007-03-31 | 55.30% |
| 2006-12-31 | 11.57% |
| 2006-09-30 | 7.66% |
| 2006-06-30 | 9.22% |
| 2006-03-31 | 2.57% |
| 2005-12-31 | -8.82% |
| 2005-09-30 | -7.37% |
| 2005-06-30 | 0.81% |
| 2005-03-31 | -1.91% |
| 2004-12-31 | -0.76% |
| 2004-09-30 | 4.90% |
| 2004-06-30 | 7.94% |
| 2004-03-31 | 4.52% |
| 2003-12-31 | -10.74% |
| 2003-09-30 | -60.60% |
| 2003-06-30 | -43.35% |
| 2003-03-31 | -30.98% |
| 2002-12-31 | -83.66% |
| 2002-09-30 | -652.51% |
